Related Experiment Video
Updated: Jun 10, 2026
09:38
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Melanocyte transplant in piebaldism: case report
Daniela Rezende Neves1, José Rogério Régis Júnior, Patrícia Jannuzzi Vieira e Oliveira
1Santa Casa Hospital of Belo Horizonte, MG, Brazil. rezendeneves.daniela@gmail.com
Anais Brasileiros De Dermatologia
|August 3, 2010
Summary
Piebaldism, a rare skin condition, typically doesn't respond to standard treatments. Minigrafting with noncultured melanocytes offers a promising transplant technique for repigmentation in affected individuals.
Area of Science:
- Dermatology
- Regenerative Medicine
- Genetics
Background:
- Piebaldism is a rare autosomal dominant genodermatosis.
- Characterized by congenital, patchy, depigmented areas due to a lack of melanocytes.
- Conventional treatments like topical therapies and light treatments are generally ineffective.
Observation:
- Depigmented skin areas in piebaldism are resistant to standard therapies.
- Melanocyte transplantation presents a potential therapeutic avenue.
- Noncultured melanocyte transplantation, or minigrafting, is explored.
Findings:
- Minigrafting using noncultured melanocytes is highlighted as an important treatment.
- This technique facilitates the repigmentation of depigmented skin.
- Successful application of melanocyte transplantation in piebaldism.
Implications:
- Minigrafting offers a viable therapeutic strategy for piebaldism.
- Advances in melanocyte transplantation could improve patient outcomes.
- Further research into regenerative approaches for genodermatoses is warranted.
